Abstract
Genetic Engineering & Biotechnology NewsVol. 40, No. 9 News & AnalysisA Unicorn Rivalry: Shaping the Future of the Synbio IndustryContrasting visions are held by Ginkgo Bioworks, which sees itself as part of a distributed ecosystem, and Zymergen, which sees itself as a one-stop shopMatthew KirshnerMatthew KirshnerMatthew Kirshner works in life sciences consulting at Putnam Associates, focused on pharmaceutical and biotechnology organizations commercializing novel therapeutics and diagnostics. He has no professional affiliation in his work with either company referenced in this article. Website: www.putassoc.com.Search for more papers by this authorPublished Online:3 Sep 2020https://doi.org/10.1089/gen.40.09.02AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 40Issue 9Sep 2020 Information© 2020 by GEN PublishingTo cite this article:Matthew Kirshner.A Unicorn Rivalry: Shaping the Future of the Synbio Industry.Genetic Engineering & Biotechnology News.Sep 2020.10-11.http://doi.org/10.1089/gen.40.09.02Published in Volume: 40 Issue 9: September 3, 2020PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
